Results 131 to 140 of about 690,575 (314)

Mixed‐class J‐domain protein scaffolds promote expanded aggregate handling and multivalent Hsp70 engagement during functional disaggregase assembly

open access: yesFEBS Letters, EarlyView.
Protein aggregates threaten proteostasis and cell health. In human cells, Hsp70–J‐domain protein‐based disaggregases remove aggregates, but how they assemble remains unclear. Our biochemical findings show that DNAJA2‐ and DNAJB1‐containing disaggregase scaffolds enhance luciferase aggregate targeting, and that Hsp70 recruitment by both J‐domain ...
Anna Szlachcic, Nadinath B. Nillegoda
wiley   +1 more source

State-of-art on PLS Path Modeling through the available software [PDF]

open access: yes
The purpose of this paper is to present PLS Path Modeling, to describe the various options of LVPLS 1.8 and PLS-Graph 3.0 for carrying out a path model, and to comment the output of both software. PLS-Graph 3.0 is actually based on LVPLS 1.8. As an added
TENENHAUS, Michel   +2 more
core  

Reconstructing enzyme evolution by protein engineering

open access: yesFEBS Letters, EarlyView.
Natural enzyme evolution can be retraced by protein engineering methods such as directed evolution, rational design, and ancestral sequence reconstruction. These approaches reveal how enzymes emerged from ligand‐binding scaffolds, developed varying substrate preferences, formed oligomeric complexes, adapted to environmental changes, and evolved novel ...
Lukas Drexler   +2 more
wiley   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

An abstract approach towards modeling intelligent structural systems

open access: yes, 2018
Current design standards have not kept pace with the rapid developments in intelligent sensing technologies. In modern engineering practice, engineering structures and structural health monitoring (SHM) systems are considered one entity, referred to as ...
Legatiuk, Dmitrii, Smarsly, Kay
core  

Structural Equation Modeling

open access: yes, 2018
This chapter presents structural equation modeling as a tool for conducting research regarding how collections of variables may be related to each other as well as to a particular outcome or even multiple outcomes.
Kenneth Elpus, Peter Miksza
core   +1 more source

Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment

open access: yesMolecular Oncology, EarlyView.
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley   +1 more source

Application of Structural Equation Modeling (SEM) in quantitative research

open access: yes, 2017
Structural Equation Modeling for SEM is second generation statistical analysis techniques for analyzing the inter-relationships among multiple variables in a model. SEM is an extension of the general linear model (GLM) that enables a researcher to test a
Ahmad@Mohamad, Md. Fauzi
core  

Partial least squares structural equation modeling-based discrete choice modeling : an illustration in modeling hospital choice with latent class segmentation

open access: yes, 2022
The aim of this chapter is to showcase the effectiveness of partial least squares structural equation modeling (PLS-SEM) in estimating choices based on data derived from discrete choice experiments. To achieve this aim, we employ a PLS-SEM-based discrete
Lichters, Marcel   +2 more
core  

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy